Uses, adverse effects of abuse of corticosteroids. Part II.
Imam
A P
AP
Division of Rheumatology, University of California Davis, School of Medicine, USA.
Halpern
G M
GM
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002493:Central Nervous System Diseases / Q000209:etiology; D002648:Child; D003872:Dermatitis / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology; D005128:Eye Diseases / Q000139:chemically induced / Q000188:drug therapy; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007239:Infections / Q000209:etiology; D008659:Metabolic Diseases / Q000139:chemically induced; D009135:Muscular Diseases / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D010437:Peptic Ulcer / Q000139:chemically induced; D010913:Pituitary-Adrenal System / Q000187:drug effects; D012216:Rheumatic Diseases / Q000188:drug therapy; D019966:Substance-Related Disorders
D000305:Adrenal Cortex Hormones